Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Dow
Express Scripts
Moodys
Baxter

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011459


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 011459 describes VISTARIL, which is a drug marketed by Pfizer and is included in three NDAs. It is available from two suppliers. Additional details are available on the VISTARIL profile page.

The generic ingredient in VISTARIL is hydroxyzine hydrochloride. There are nineteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the hydroxyzine hydrochloride profile page.
Summary for 011459
Tradename:VISTARIL
Applicant:Pfizer
Ingredient:hydroxyzine pamoate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 011459
Suppliers and Packaging for NDA: 011459
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VISTARIL hydroxyzine pamoate CAPSULE;ORAL 011459 NDA Pfizer Laboratories Div Pfizer Inc 0069-5410 0069-5410-66 100 CAPSULE in 1 BOTTLE (0069-5410-66)
VISTARIL hydroxyzine pamoate CAPSULE;ORAL 011459 NDA Pfizer Laboratories Div Pfizer Inc 0069-5420 0069-5420-66 100 CAPSULE in 1 BOTTLE (0069-5420-66)

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 25MG HYDROCHLORIDE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 50MG HYDROCHLORIDE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 006

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Dow
Harvard Business School
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.